New 5-hydroxytryptamine1A receptor ligands containing a norbornene nucleus: Synthesis and in vitro pharmacological evaluation

Ferdinande Fiorino, Elisa Perissutti, Beatrice Severino, Vincenzo Santagada, Donatella Cirillo, Sara Terracciano, Paola Massarelli, Giancarlo Bruni, Elga Collavoli, Christian Renner, Giuseppe Caliendo

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

New arylpiperazine derivatives were prepared to identify highly selective and potent ligands for the 5-hydroxytryptamine 1A (5-HT1A) receptor as potential pharmacological tools in studies of central nervous system (CNS) disorders. The combination of structural elements (heterocyclic nucleus, oxyalkyl chain, and arylpiperazine) known to introduce 5-HT1A receptor affinity and the proper selection of substituents led to compounds with higher receptor specificity and affinity. In binding studies, several molecules showed affinity in the nanomolar and subnanomolar ranges at 5-HT1A and moderate to no affinity for other relevant receptors (5-HT2A, 5-HT2C, D1, D2, α1, and α2). The 4-[3-[4-(o-methoxyphenyl)piperazin-1-yl]propoxy]-4- aza-tricyclo-[5.2.1.02,6]dec-8-ene-3,5-dione (3b), with Ki = 0.021 nM, was the most active and selective derivative for the 5-HT1A receptor with respect to other serotonin receptors, whereas the most selective derivative for dopaminergic and adrenergic receptors was a CF 3-substituted arylpiperazine (2e). As a general trend, compounds with a piperazinylpropoxy chain (3b-g) showed a preferential affinity for the 5-HT1A receptor, suggesting that the alkyl chain length represents a critical structural feature in determining 5-HT1A receptor affinity and selectivity, as confirmed by the molecular modeling invoked for explaining the differential binding affinities of the new arylpiperazines.

Original languageEnglish
Pages (from-to)5495-5503
Number of pages9
JournalJournal of Medicinal Chemistry
Volume48
Issue number17
DOIs
Publication statusPublished - Aug 25 2005

Fingerprint

Receptor, Serotonin, 5-HT1A
Pharmacology
Ligands
Derivatives
Receptor, Serotonin, 5-HT2C
Molecular modeling
Serotonin Receptors
Central Nervous System Diseases
Neurology
Chain length
Adrenergic Receptors
Serotonin
2-norbornene
In Vitro Techniques
Molecules

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Fiorino, F., Perissutti, E., Severino, B., Santagada, V., Cirillo, D., Terracciano, S., ... Caliendo, G. (2005). New 5-hydroxytryptamine1A receptor ligands containing a norbornene nucleus: Synthesis and in vitro pharmacological evaluation. Journal of Medicinal Chemistry, 48(17), 5495-5503. https://doi.org/10.1021/jm050246k

New 5-hydroxytryptamine1A receptor ligands containing a norbornene nucleus : Synthesis and in vitro pharmacological evaluation. / Fiorino, Ferdinande; Perissutti, Elisa; Severino, Beatrice; Santagada, Vincenzo; Cirillo, Donatella; Terracciano, Sara; Massarelli, Paola; Bruni, Giancarlo; Collavoli, Elga; Renner, Christian; Caliendo, Giuseppe.

In: Journal of Medicinal Chemistry, Vol. 48, No. 17, 25.08.2005, p. 5495-5503.

Research output: Contribution to journalArticle

Fiorino, F, Perissutti, E, Severino, B, Santagada, V, Cirillo, D, Terracciano, S, Massarelli, P, Bruni, G, Collavoli, E, Renner, C & Caliendo, G 2005, 'New 5-hydroxytryptamine1A receptor ligands containing a norbornene nucleus: Synthesis and in vitro pharmacological evaluation', Journal of Medicinal Chemistry, vol. 48, no. 17, pp. 5495-5503. https://doi.org/10.1021/jm050246k
Fiorino, Ferdinande ; Perissutti, Elisa ; Severino, Beatrice ; Santagada, Vincenzo ; Cirillo, Donatella ; Terracciano, Sara ; Massarelli, Paola ; Bruni, Giancarlo ; Collavoli, Elga ; Renner, Christian ; Caliendo, Giuseppe. / New 5-hydroxytryptamine1A receptor ligands containing a norbornene nucleus : Synthesis and in vitro pharmacological evaluation. In: Journal of Medicinal Chemistry. 2005 ; Vol. 48, No. 17. pp. 5495-5503.
@article{5a5ae65e0c1040029f0413bbaace5ff8,
title = "New 5-hydroxytryptamine1A receptor ligands containing a norbornene nucleus: Synthesis and in vitro pharmacological evaluation",
abstract = "New arylpiperazine derivatives were prepared to identify highly selective and potent ligands for the 5-hydroxytryptamine 1A (5-HT1A) receptor as potential pharmacological tools in studies of central nervous system (CNS) disorders. The combination of structural elements (heterocyclic nucleus, oxyalkyl chain, and arylpiperazine) known to introduce 5-HT1A receptor affinity and the proper selection of substituents led to compounds with higher receptor specificity and affinity. In binding studies, several molecules showed affinity in the nanomolar and subnanomolar ranges at 5-HT1A and moderate to no affinity for other relevant receptors (5-HT2A, 5-HT2C, D1, D2, α1, and α2). The 4-[3-[4-(o-methoxyphenyl)piperazin-1-yl]propoxy]-4- aza-tricyclo-[5.2.1.02,6]dec-8-ene-3,5-dione (3b), with Ki = 0.021 nM, was the most active and selective derivative for the 5-HT1A receptor with respect to other serotonin receptors, whereas the most selective derivative for dopaminergic and adrenergic receptors was a CF 3-substituted arylpiperazine (2e). As a general trend, compounds with a piperazinylpropoxy chain (3b-g) showed a preferential affinity for the 5-HT1A receptor, suggesting that the alkyl chain length represents a critical structural feature in determining 5-HT1A receptor affinity and selectivity, as confirmed by the molecular modeling invoked for explaining the differential binding affinities of the new arylpiperazines.",
author = "Ferdinande Fiorino and Elisa Perissutti and Beatrice Severino and Vincenzo Santagada and Donatella Cirillo and Sara Terracciano and Paola Massarelli and Giancarlo Bruni and Elga Collavoli and Christian Renner and Giuseppe Caliendo",
year = "2005",
month = "8",
day = "25",
doi = "10.1021/jm050246k",
language = "English",
volume = "48",
pages = "5495--5503",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "17",

}

TY - JOUR

T1 - New 5-hydroxytryptamine1A receptor ligands containing a norbornene nucleus

T2 - Synthesis and in vitro pharmacological evaluation

AU - Fiorino, Ferdinande

AU - Perissutti, Elisa

AU - Severino, Beatrice

AU - Santagada, Vincenzo

AU - Cirillo, Donatella

AU - Terracciano, Sara

AU - Massarelli, Paola

AU - Bruni, Giancarlo

AU - Collavoli, Elga

AU - Renner, Christian

AU - Caliendo, Giuseppe

PY - 2005/8/25

Y1 - 2005/8/25

N2 - New arylpiperazine derivatives were prepared to identify highly selective and potent ligands for the 5-hydroxytryptamine 1A (5-HT1A) receptor as potential pharmacological tools in studies of central nervous system (CNS) disorders. The combination of structural elements (heterocyclic nucleus, oxyalkyl chain, and arylpiperazine) known to introduce 5-HT1A receptor affinity and the proper selection of substituents led to compounds with higher receptor specificity and affinity. In binding studies, several molecules showed affinity in the nanomolar and subnanomolar ranges at 5-HT1A and moderate to no affinity for other relevant receptors (5-HT2A, 5-HT2C, D1, D2, α1, and α2). The 4-[3-[4-(o-methoxyphenyl)piperazin-1-yl]propoxy]-4- aza-tricyclo-[5.2.1.02,6]dec-8-ene-3,5-dione (3b), with Ki = 0.021 nM, was the most active and selective derivative for the 5-HT1A receptor with respect to other serotonin receptors, whereas the most selective derivative for dopaminergic and adrenergic receptors was a CF 3-substituted arylpiperazine (2e). As a general trend, compounds with a piperazinylpropoxy chain (3b-g) showed a preferential affinity for the 5-HT1A receptor, suggesting that the alkyl chain length represents a critical structural feature in determining 5-HT1A receptor affinity and selectivity, as confirmed by the molecular modeling invoked for explaining the differential binding affinities of the new arylpiperazines.

AB - New arylpiperazine derivatives were prepared to identify highly selective and potent ligands for the 5-hydroxytryptamine 1A (5-HT1A) receptor as potential pharmacological tools in studies of central nervous system (CNS) disorders. The combination of structural elements (heterocyclic nucleus, oxyalkyl chain, and arylpiperazine) known to introduce 5-HT1A receptor affinity and the proper selection of substituents led to compounds with higher receptor specificity and affinity. In binding studies, several molecules showed affinity in the nanomolar and subnanomolar ranges at 5-HT1A and moderate to no affinity for other relevant receptors (5-HT2A, 5-HT2C, D1, D2, α1, and α2). The 4-[3-[4-(o-methoxyphenyl)piperazin-1-yl]propoxy]-4- aza-tricyclo-[5.2.1.02,6]dec-8-ene-3,5-dione (3b), with Ki = 0.021 nM, was the most active and selective derivative for the 5-HT1A receptor with respect to other serotonin receptors, whereas the most selective derivative for dopaminergic and adrenergic receptors was a CF 3-substituted arylpiperazine (2e). As a general trend, compounds with a piperazinylpropoxy chain (3b-g) showed a preferential affinity for the 5-HT1A receptor, suggesting that the alkyl chain length represents a critical structural feature in determining 5-HT1A receptor affinity and selectivity, as confirmed by the molecular modeling invoked for explaining the differential binding affinities of the new arylpiperazines.

UR - http://www.scopus.com/inward/record.url?scp=23944472607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23944472607&partnerID=8YFLogxK

U2 - 10.1021/jm050246k

DO - 10.1021/jm050246k

M3 - Article

C2 - 16107148

AN - SCOPUS:23944472607

VL - 48

SP - 5495

EP - 5503

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 17

ER -